IPHA’s ‘Innovate For Life’ Tells Impact And Value Story For Ireland’s Pharmaceutical Innovators

The Irish Pharmaceutical Healthcare Association (IPHA), which represents the originator pharmaceutical industry, today [Monday] launched ‘Innovate for Life’, a public campaign aimed at telling a value story about the impact of medicines in society.

Read more

Public urged to proactively manage health all year round

The development and adoption of self care in the Irish health system needs to be an all year effort according to the Irish Pharmacy Union (IPU) and the Irish Pharmaceutical Healthcare Association (IPHA). The two bodies have today launched a new self care awareness campaign, entitled ‘Be Well this Summer – Think Pharmacy’ designed to highlight the benefits to the public of looking after their health during the summer period.

 

Read more

Future Of Medicines Pricing And Supply Will Be ‘Radically Different’, IPHA Tells NCPE Conference

  • Pace of pharmaceutical innovation means change in the reimbursement model is inevitable
  • Funding for new medicines will be greater than the opportunity to save on older medicines
  • Medicines spending must be considered an ‘investment in outcomes’

Read more

Ireland Can Be A European Leader In Clinical Trials, IPHA Tells HRB-CRCI Conference

Ahead of International Clinical Trials Day, pharmaceutical innovators call for:

  • The standardisation of site contracts (the Clinical Trial Agreement), in place in most other EU countries
  • Protected research time for clinicians and hospital staff
  • Realistic targets for clinical trials that are achievable and can be relied upon
  • Partnership approach between clinicians, policymakers, patients and industry to eliminate delays recruiting patients

Read more

IPHA attends ICHOM annual conference on value based healthcare in Rotterdam.

Orlaith Brennan,  IPHA Director of Commercial Affairs, recently attended the ICHOM annual conference on value based healthcare in Rotterdam.

ICHOM is the International Consortium for Healthcare Outcomes Management and was co-founded by Professor Michael Porter of the Harvard Business School.

Read more

Intellectual property must be safeguarded to ensure ongoing breakthroughs in innovative medicines

On World IP Day, pharmaceutical innovators say it’s vital that the intellectual property (IP) rights that enhance the development of innovative medicines in Europe are protected and not further eroded.

Read more

Pharmaceutical Industry Must Be Part of New Government Alliance to Boost Vaccination Rates

On World Immunisation Week, pharmaceutical innovators say it’s vital to take steps to reduce vaccine hesitancy and to dispel ‘damaging’ myths about vaccination.

Read more